I guess a lot of tech stock are being valued based on future...

I guess a lot of tech stock are being valued based on future even though they may not be making money currently

It all depends on whether they can be at the forefront of their technology and being used by consumers which gives them the market share, turnover, data collection and eventually use that to branch into other areas, work or merge with other companies to be an even bigger giant.

As a user on the business side and the consumer side, I can see where they are going. There are competitions coming out (eg. Fred IT, which is also a pretty big dispensing software) which will compete in this space to link with Escripts (erx). Medadvisor is doing that ok.

I see them being used by small pharmacies, Terry Whites, National Pharmacies (currently a dying group). Pharmacies are now starting to see the benefits of this app with patients keeping their scripts instore which will push this space further.

App is not bad, can be improved further and they're doing that slowly with the interface.

The only thing I would say is for the company to grow further, they do need to spend on their marketing with sales reps going out to pharmacies to use their app with more follow ups (which I've never met) to capture market share. Unless they've been doing that at the higher end which I don't see. Otherwise, they will be push aside by companies that have dispensing softwares which may monopolise the market by offering better deals to link with their dispensing system to order scripts online.

It all comes down to management and how involved are they, looking at the user end (doctors, pharmacy and consumers) and meeting their needs at the environment. We can only hope (if any of them is reading this). Having retail pharmacists with good management/business acumen will help.